These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 8910675)

  • 21. The BH3 domain of Bcl-x(S) is required for inhibition of the antiapoptotic function of Bcl-x(L).
    Chang BS; Kelekar A; Harris MH; Harlan JE; Fesik SW; Thompson CB
    Mol Cell Biol; 1999 Oct; 19(10):6673-81. PubMed ID: 10490606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between structure of Bcl-2 and its inhibitory function of JNK and caspase activity in dopaminergic neuronal apoptosis.
    Choi WS; Yoon SY; Chang II; Choi EJ; Rhim H; Jin BK; Oh TH; Krajewski S; Reed JC; Oh YJ
    J Neurochem; 2000 Apr; 74(4):1621-6. PubMed ID: 10737620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bcl-XL protects BimEL-induced Bax conformational change and cytochrome C release independent of interacting with Bax or BimEL.
    Yamaguchi H; Wang HG
    J Biol Chem; 2002 Nov; 277(44):41604-12. PubMed ID: 12198137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MAP-1, a novel proapoptotic protein containing a BH3-like motif that associates with Bax through its Bcl-2 homology domains.
    Tan KO; Tan KM; Chan SL; Yee KS; Bevort M; Ang KC; Yu VC
    J Biol Chem; 2001 Jan; 276(4):2802-7. PubMed ID: 11060313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative genomics: the evolutionary history of the Bcl-2 family.
    Lanave C; Santamaria M; Saccone C
    Gene; 2004 May; 333():71-9. PubMed ID: 15177682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bcl-x(S) can form homodimers and heterodimers and its apoptotic activity requires localization of Bcl-x(S) to the mitochondria and its BH3 and loop domains.
    Lindenboim L; Borner C; Stein R
    Cell Death Differ; 2001 Sep; 8(9):933-42. PubMed ID: 11526448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
    Modi V; Lama D; Sankararamakrishnan R
    J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bcl-xES, a BH4- and BH2-containing antiapoptotic protein, delays Bax oligomer formation and binds Apaf-1, blocking procaspase-9 activation.
    Schmitt E; Paquet C; Beauchemin M; Bertrand R
    Oncogene; 2004 May; 23(22):3915-31. PubMed ID: 15048082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bcl-2 is a monomeric protein: prevention of homodimerization by structural constraints.
    Conus S; Kaufmann T; Fellay I; Otter I; Rossé T; Borner C
    EMBO J; 2000 Apr; 19(7):1534-44. PubMed ID: 10747022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities.
    D'Sa-Eipper C; Chinnadurai G
    Oncogene; 1998 Jun; 16(24):3105-14. PubMed ID: 9671389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deletion of the BH1 domain of Bcl-2 accelerates apoptosis by acting in a dominant negative fashion.
    Kawatani M; Imoto M
    J Biol Chem; 2003 May; 278(22):19732-42. PubMed ID: 12644466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regions outside of the Bcl-2 homology domains, BH1 and BH2 protect a dopaminergic neuronal cell line from staurosporine-induced cell death.
    Oh YJ; Uhland-Smith A; Kim JE; O'Malley KL
    Brain Res Mol Brain Res; 1997 Nov; 51(1-2):133-42. PubMed ID: 9427515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural basis of BFL-1 for its interaction with BAX and its anti-apoptotic action in mammalian and yeast cells.
    Zhang H; Cowan-Jacob SW; Simonen M; Greenhalf W; Heim J; Meyhack B
    J Biol Chem; 2000 Apr; 275(15):11092-9. PubMed ID: 10753914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A common binding site mediates heterodimerization and homodimerization of Bcl-2 family members.
    Diaz JL; Oltersdorf T; Horne W; McConnell M; Wilson G; Weeks S; Garcia T; Fritz LC
    J Biol Chem; 1997 Apr; 272(17):11350-5. PubMed ID: 9111042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites.
    Ray R; Chen G; Vande Velde C; Cizeau J; Park JH; Reed JC; Gietz RD; Greenberg AH
    J Biol Chem; 2000 Jan; 275(2):1439-48. PubMed ID: 10625696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Puma(*)Mcl-1 interaction is not sufficient to prevent rapid degradation of Mcl-1.
    Mei Y; Du W; Yang Y; Wu M
    Oncogene; 2005 Nov; 24(48):7224-37. PubMed ID: 16007132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide screening to knockdown Bcl-2's anti-apoptotic activity: implications in cancer treatment.
    Raghav PK; Verma YK; Gangenahalli GU
    Int J Biol Macromol; 2012 Apr; 50(3):796-814. PubMed ID: 22155216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural conservation of residues in BH1 and BH2 domains of Bcl-2 family proteins.
    Gurudutta GU; Verma YK; Singh VK; Gupta P; Raj HG; Sharma RK; Chandra R
    FEBS Lett; 2005 Jul; 579(17):3503-7. PubMed ID: 15949801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cell death machinery controlled by Bax and Bcl-XL is evolutionarily conserved in Ciona intestinalis.
    Takada N; Yamaguchi H; Shida K; Terajima D; Satou Y; Kasuya A; Satoh N; Satake M; Wang HG
    Apoptosis; 2005 Dec; 10(6):1211-20. PubMed ID: 16215691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenovirus E1B-19K/BCL-2 interacting protein BNIP3 contains a BH3 domain and a mitochondrial targeting sequence.
    Yasuda M; Theodorakis P; Subramanian T; Chinnadurai G
    J Biol Chem; 1998 May; 273(20):12415-21. PubMed ID: 9575197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.